Tradestie Institutional Equity Comparison Engine

IMMP vs BHST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMMP Overall Edge

IMMP Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immutep Limited American Depositary Shares (IMMP) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IMMP trades at 7.1x Forward P/E with -409.3% operating margin (+633.5% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, IMMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IMMP
IMMP 7.1x vs BHST N/M Fwd P/E
Growth & Margin Winner IMMP
Op Margin -409.3% vs -18.0% ยท YoY +633.5% vs +3.8%
Momentum & Technical Winner IMMP
1Y +73.7% vs -79.4% ยท 52W Pos 56% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IMMP NASDAQ
Immutep Limited American Depositary Shares
Pharmaceutical Preparations
$3.11
-9.06% 1D
Market Cap $25.2M
1M Return -1.89%
1Y Return +73.74%
Forward P/E 7.1x
Unified AI Score
58.4 / 100 HOLD
Tech 62.0 Fund 38.0 Flow 50.0 Mom 40.0
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMMP +73.74% BHST -79.4% Spread: +161.27 pp (IMMP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMMP TTM Op. Margin: -409.3% BHST TTM Op. Margin: -18.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMMP vs BHST. Trailing 12-month operating profitability (IMMP -409.3% vs BHST -18.0%) and valuation multiples (IMMP 7.1x vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMMP (6) vs BHST (2)
Institutional Metric IMMP BHST Criterion Row Winner
Market Capitalization Scale $25.2M $29.9M Larger Scale Tie
Trailing P/E Ratio Valuation 7.1x N/M Lower Multiple IMMP
Forward P/E Ratio Valuation 7.1x N/M Lower Multiple IMMP
Revenue Growth (YoY) Growth +633.5% +3.8% Higher Growth IMMP
Operating Margin (TTM) Profitability -409.3% -18.0% Higher Margin BHST
Net Profit Margin Profitability 0.0% -31.2% Higher Margin IMMP
Return on Equity (ROE) Capital Efficiency -77.3% -142.5% Higher ROE IMMP
52-Week Range Position Momentum 56% ($0โ€“$5) 6% ($1โ€“$7) Stronger Trend IMMP
Beta / 30D Volatility Risk Regime -7.10ฮฒ ยท 118% Vol 0.25ฮฒ ยท 86% Vol Lower Realized Risk BHST
Unified Institutional Score Composite Signal 58.4 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMMP vs BHST Buy Guide
IMMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IMMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMMP nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.